0 0 Shinkar Medical Services Ltd 11913342 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 11913342 2024-04-01 2025-03-31 11913342 2025-03-31 11913342 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 11913342 core:MotorVehicles 2025-03-31 11913342 core:PlantMachinery 2025-03-31 11913342 bus:SmallEntities 2024-04-01 2025-03-31 11913342 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 11913342 bus:FilletedAccounts 2024-04-01 2025-03-31 11913342 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11913342 bus:RegisteredOffice 2024-04-01 2025-03-31 11913342 bus:Director1 2024-04-01 2025-03-31 11913342 bus:Director2 2024-04-01 2025-03-31 11913342 bus:Director3 2024-04-01 2025-03-31 11913342 bus:Director4 2024-04-01 2025-03-31 11913342 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11913342 bus:Agent1 2024-04-01 2025-03-31 11913342 core:MotorVehicles 2024-04-01 2025-03-31 11913342 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 11913342 core:PlantMachinery 2024-04-01 2025-03-31 11913342 core:Vehicles 2024-04-01 2025-03-31 11913342 countries:EnglandWales 2024-04-01 2025-03-31 11913342 2024-03-31 11913342 core:MotorVehicles 2024-03-31 11913342 core:PlantMachinery 2024-03-31 11913342 2023-04-01 2024-03-31 11913342 2024-03-31 11913342 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 11913342 core:MotorVehicles 2024-03-31 11913342 core:PlantMachinery 2024-03-31 xbrli:pure iso4217:GBP

Registration number: 11913342

Shinkar Medical Services Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Shinkar Medical Services Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 6

Shinkar Medical Services Ltd

Company Information

Directors | Anurag Shinkar Dr Madhuri Shinkar Dr Rajeev Shinkar Kalyani Shinkar

Registered office | 5 Ducketts Wharf South Street Bishop's Stortford Hertfordshire CM23 3AR

Accountants | Mansell & Co Chartered Certified Accountants5 Ducketts Wharf South Street Bishop Stortford Hertfordshire CM23 3AR

Shinkar Medical Services Ltd

(Registration number: 11913342)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 31,802 | 44,788
Current assets |  |  |
Cash at bank and in hand |  | 286,000 | 216,552
Creditors: Amounts falling due within one year | 5 | (28,831) | (32,407)
Net current assets |  | 257,169 | 184,145
Total assets less current liabilities |  | 288,971 | 228,933
Provisions for liabilities |  | (7,213) | (8,510)
Net assets |  | 281,758 | 220,423
Capital and reserves |  |  |
Called up share capital | 6 | 100 | 100
Retained earnings |  | 281,658 | 220,323
Shareholders' funds |  | 281,758 | 220,423

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 19 November 2025 and signed on its behalf by:

......................................... Dr Rajeev Shinkar Director

Shinkar Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
5 Ducketts Wharf
South Street
Bishop's Stortford
Hertfordshire
CM23 3AR
England

These financial statements were authorised for issue by the Board on 19 November 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Shinkar Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and equipment | 4 years straight line basis
Vehicles | 25% reducing balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Shinkar Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

4 | Tangible assets

| Plant and equipment £ | Motor vehicles £ | Total £
Cost or valuation
At 1 April 2024 | 10,488 | 72,798 | 83,286
Additions | 1,263 | - | 1,263
At 31 March 2025 | 11,751 | 72,798 | 84,549
Depreciation
At 1 April 2024 | 6,192 | 32,306 | 38,498
Charge for the year | 4,126 | 10,123 | 14,249
At 31 March 2025 | 10,318 | 42,429 | 52,747
Carrying amount
At 31 March 2025 | 1,433 | 30,369 | 31,802
At 31 March 2024 | 4,296 | 40,492 | 44,788

5 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 22,379 | 18,507
Accruals and deferred income | 1,168 | 900
Other creditors | 5,284 | 13,000
| 28,831 | 32,407

Shinkar Medical Services Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 100 | 100 | 100 | 100